ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,309Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 337

$1.75M Total Retail Price of All Prescriptions

Rank: 3 out of 337

643 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 643 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 29,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 1,511 1,426 1 11
TRAZODONE HCL 1,264 1,149 2 16
FUROSEMIDE 1,200 1,131 3 8
LEVOTHYROXINE SODIUM 1,106 1,025 4 5
SIMVASTATIN 969 868 5 1
METOPROLOL TARTRATE 887 818 6 6
MIRTAZAPINE 822 785 7 27
OMEPRAZOLE 796 723 8 4
SERTRALINE HCL 787 751 9 18
AMLODIPINE BESYLATE 772 726 10 3
DONEPEZIL HCL 767 751 11 22
CITALOPRAM HBR 614 567 12 17
LISINOPRIL 567 531 13 2
NAMENDA 492 478 14 35
TRAMADOL HCL 464 439 15 32
GABAPENTIN 453 384 16 20
LANTUS 366 307 17 49
SPIRIVA 330 303 18 43
LIDODERM 329 302 19 82
TAMSULOSIN HCL 296 285 20 25
QUETIAPINE FUMARATE 296 273 20 61
POTASSIUM CHLORIDE 293 273 22 62
RISPERIDONE 292 248 23 72
HYDROCODONE-ACETAMINOPHEN 288 149 S3 24 13
POLYETHYLENE GLYCOL 3350 265 253 25 47
RAMIPRIL 243 228 26 80
ATENOLOL 229 227 27 10
CLOPIDOGREL 229 220 27 42
RANITIDINE HCL 228 215 29 30
ESCITALOPRAM OXALATE 225 201 30 66
EXELON 222 206 31 85
ISOSORBIDE MONONITRATE ER 215 212 32 70
GLIPIZIDE 210 195 33 45
CARVEDILOL 204 195 34 73
PREDNISONE 197 184 35 40
PRAVASTATIN SODIUM 195 176 36 14
DILTIAZEM 24HR CD 189 188 37 104
METFORMIN HCL 185 181 38 12
IPRATROPIUM-ALBUTEROL 184 173 39 96
NYSTATIN 180 167 40 125
ATORVASTATIN CALCIUM 177 163 41 7
OXYCODONE HCL 173 91 S2 42 63
FINASTERIDE 165 165 43 83
PAROXETINE HCL 164 155 44 46
HYDROCHLOROTHIAZIDE 164 140 44 9
CIPROFLOXACIN HCL 157 147 46 71
ADVAIR DISKUS 150 140 47 44
CARBIDOPA-LEVODOPA 147 132 48 92
AVELOX 147 138 48 184
PANTOPRAZOLE SODIUM 145 127 50 36
OXYCONTIN 145 78 S2 50 87
METOPROLOL SUCCINATE 141 132 52 21
CYMBALTA 140 118 53 59
VENLAFAXINE HCL ER 139 115 54 86
ZOLPIDEM TARTRATE 138 67 55 23
HUMALOG 135 109 56 153
DIVALPROEX SODIUM 135 103 56 101
BUSPIRONE HCL 134 133 58 129
LOSARTAN POTASSIUM 133 130 59 15
DIOVAN 132 118 60 26
DIGOXIN 130 120 61 58
LEVETIRACETAM 130 112 61 112
HYDRALAZINE HCL 129 120 63 122
SEROQUEL 126 102 64 107
PLAVIX 123 117 65 74
FLUTICASONE PROPIONATE 118 111 66 34
LACTULOSE 114 88 67 105
FAMOTIDINE 113 113 68 115
ALENDRONATE SODIUM 111 111 69 19
DOXAZOSIN MESYLATE 106 94 70 68
LEVOFLOXACIN 105 96 71 93
SPIRONOLACTONE 101 101 72 100
CEPHALEXIN 100 88 73 130
ALLOPURINOL 98 92 74 28
FLUOXETINE HCL 91 90 75 57
OXYCODONE-ACETAMINOPHEN 90 64 S2 76 84
LATANOPROST 90 90 76 120
ABILIFY 90 90 76 145
BRIMONIDINE TARTRATE 88 88 79 161
AZITHROMYCIN 85 68 80 51
OXYBUTYNIN CHLORIDE 84 63 81 143
OLANZAPINE 80 80 82 108
TERAZOSIN HCL 79 79 83 136
DILTIAZEM HCL 79 70 83 177
GLIPIZIDE ER 78 76 85 69
NOVOLOG 78 66 85 106
JANUVIA 77 77 87 81
FENTANYL 74 67 S2 88 138
VENTOLIN HFA 74 63 88 159
LIDOCAINE 72 71 90 225
ENALAPRIL MALEATE 70 57 91 37
AMOX TR-POTASSIUM CLAVULANATE 70 63 91 137
NITROFURANTOIN 69 68 93 237
AMIODARONE HCL 69 68 93 293
PROAIR HFA 68 56 95 38
DILANTIN 66 58 96 191
CLONIDINE 65 65 97 297
ERYTHROMYCIN 64 64 98 202
HALOPERIDOL 64 64 98 189
HYDROXYZINE HCL 63 42 R 100 179
TRAVATAN Z 63 63 100 160
BUPROPION HCL SR 62 62 102 154
VANCOMYCIN HCL 61 58 103 192
CRESTOR 61 57 103 29
PHENYTOIN SODIUM EXTENDED 61 47 103 150
BUPROPION HCL 60 55 106 228
RIVASTIGMINE 59 59 107 208
MUPIROCIN 59 50 107 200
ALBUTEROL SULFATE 59 58 107 131
FENOFIBRATE 59 58 107 48
NITROFURANTOIN MONO-MACRO 59 54 107 197
LITHIUM CARBONATE 58 51 112 232
BISOPROLOL FUMARATE 58 58 112 67
CLOZAPINE 58 58 112 94
CHOLESTYRAMINE 58 57 112 253
OXYBUTYNIN CHLORIDE ER 57 56 116 124
GLUCAGEN 57 56 116 255
MELOXICAM 54 32 118 54
LANTUS SOLOSTAR 54 40 118 146
NOVOLIN N 53 42 120 313
ROPINIROLE HCL 53 52 120 141
LAMOTRIGINE 52 35 122 188
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 39 122 139
NORTRIPTYLINE HCL 52 52 122 260
SINGULAIR 52 41 122 113
PROCHLORPERAZINE MALEATE 52 41 122 222
TAMIFLU 51 48 127 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.